Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2007
11/29/2007WO2007136574A2 Medical devices having polymeric regions based on vinyl ether block copolymers
11/29/2007WO2007136573A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136572A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007135970A1 Heterocyclic type cinnamide derivative
11/29/2007WO2007135527A2 Benzimidazolyl compounds
11/29/2007WO2007134864A1 Indole derivatives and their use as thyroid receptor ligands
11/29/2007WO2007134677A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007WO2007134457A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007WO2007090836A3 Piperidine derivatives as cxcr3 receptor antagonists
11/29/2007WO2007084413A3 Methods for treating hepatitis c
11/29/2007WO2007045893A3 Beta adrenergic receptor pharmacophore
11/29/2007US20070275968 Substituted Biphenyl Derivative
11/29/2007US20070275967 Pyrazolinols
11/29/2007US20070275966 4'-(2-Oxo-5-(R)-phenyl-oxazolidin-3-ylmethyl) biphenyl-3-carboxylic acid (2-dimethylamino-ethyl)-amide, usedd for the treatment or prevention of neurological and psychiatric disorders
11/29/2007US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007US20070275962 Heterobicyclic Compounds as Pharmaceutically Active Agents
11/29/2007US20070275961 Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
11/29/2007US20070275960 Phenyl and pyridyl compounds for inflammation and immune-related uses
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275952 Tie-2 Modulators and Methods of Use
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007CA2652484A1 Heterocyclic type cinnamide derivative
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2651700A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2651134A1 Indole derivatives and their use as thyroid receptor ligands
11/29/2007CA2650611A1 Compositions and methods for fgf receptor kinases inhibitors
11/29/2007CA2649913A1 N-benzoyl- and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/28/2007EP1860100A2 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
11/28/2007EP1858901A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858858A2 Method for producing alkyl anilides
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858849A1 Organic compounds
11/28/2007EP1858846A1 Dpp-iv inhibitors
11/28/2007EP1858327A1 Use of 4-aminopyrimidines for the prevention of fungal pests novel 4-aminopyrimidines method for production thereof and agents comprising the same
11/28/2007EP1725543B1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN101080405A Quaternary ammonium salts as M3 antagonists
11/28/2007CN101080404A Pyrimidinylisoxazol derivative
11/28/2007CN101080228A Piperazinyl-pyridine analogues
11/28/2007CN101080226A Amido compounds and their use as pharmaceuticals
11/28/2007CN101077867A Bis-aryl sulfonamides
11/28/2007CN101077866A Substituted benzoxazoles antifungal compounds and preparation method thereof
11/28/2007CN100351252C Novel process for the synthesis of carboxylic acid phenylamide
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/27/2007US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007US7301034 Reacting a 4-bromoaniline derivative with a dialkyl disulfide in presence of a nitrite and a catalyst in a suitable solvent
11/27/2007US7300946 For use in controlling insects; controlling tobacco budworm
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300933 Diazabicyclic biaryl derivatives
11/27/2007US7300932 For treatment or prevention of metabolic and cell proliferative diseases; modifying lipid metabolism
11/27/2007US7300930 Therapeutic acridone and acridine compounds
11/27/2007US7300928 Benzimidazolidinone derivatives as muscarinic agents
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007WO2007133615A2 Hand-held aspiration syringe and methods
11/22/2007WO2007133491A1 Substituted spirocyclic cgrp receptor antagonists
11/22/2007WO2007133108A1 Pharmaceutical composition, method for the production and the use thereof
11/22/2007WO2007132307A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
11/22/2007WO2007131953A1 A new process for the synthesis of 2-aminoxazole compounds
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131622A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
11/22/2007WO2007120595A3 Amines for the treatment of hcv
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007104772A9 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments
11/22/2007WO2007077961A3 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2007025247A3 Transglutaminase inhibitors and methods of use thereof
11/22/2007WO2006135839A3 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
11/22/2007WO2006129158A3 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
11/22/2007WO2006104915A3 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
11/22/2007WO2006076726A9 Synthesis of sodium narcistatin and related compounds
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270438 Cycloalkylamino acid derivatives
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/22/2007US20070270425 Substituted pyrimidinyl oxime kinase inhibitors
11/22/2007US20070270424 Heterocyclic inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same
11/22/2007US20070270423 Histamine 3 receptor antagonists/inverse agonists ; (4-isopropyl-piperazin-1-yl)-[1-(1-isopropyl-pyrrolidin-3-yl)-1H-indol-5-yl]-methanone; obesity, metabolic syndrome (syndrome X), and other eating disorders
11/22/2007US20070270422 Aromatic Compounds
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270412 Novel pharmaceuticals
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270399 New compounds 302
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2651817A1 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as cetp inhibitors